222 related articles for article (PubMed ID: 37304544)
1. Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods.
Yang Z; Sun R; Qu G; Wang F; Yin Z; Zhang T; Wang P; Li S; Lin S
Transl Cancer Res; 2023 May; 12(5):1112-1127. PubMed ID: 37304544
[TBL] [Abstract][Full Text] [Related]
2. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
[TBL] [Abstract][Full Text] [Related]
3. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis Identifies COL1A1, COL3A1, and POSTN as Key Genes Associated with Brain Metastasis in Patients with Breast Cancer.
Wu W; Zheng L
Evid Based Complement Alternat Med; 2022; 2022():7812218. PubMed ID: 35990840
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.
Zhang L; Wang L; Yang H; Li C; Fang C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34541602
[TBL] [Abstract][Full Text] [Related]
6. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
8. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
10. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
Wu Z; Wan J; Wang J; Meng X; Qian H
Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
[TBL] [Abstract][Full Text] [Related]
12. Identifying
Ding J; Liu Y; Lai Y
PeerJ; 2020; 8():e10419. PubMed ID: 33282565
[TBL] [Abstract][Full Text] [Related]
13. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer: A Single-Institution Retrospective Analysis from China.
Cai SL; Wang ZH; Chen XG; Han L; Gong GX; Chen YP; Lin XQ; Ma T; Chen HD
Front Oncol; 2022; 12():905065. PubMed ID: 35832552
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
PeerJ; 2018; 6():e5180. PubMed ID: 30002985
[TBL] [Abstract][Full Text] [Related]
16. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
[TBL] [Abstract][Full Text] [Related]
18. Identifying liver metastasis-related hub genes in breast cancer and characterizing
Chen M; Zheng W; Fang L
PeerJ; 2023; 11():e15311. PubMed ID: 37180578
[TBL] [Abstract][Full Text] [Related]
19. Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis.
Yang K; Gao J; Luo M
Onco Targets Ther; 2019; 12():1319-1331. PubMed ID: 30863098
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
Zhou Z; Wu B; Tang X; Ke R; Zou Q
Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
